Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Starlight: Fezolinetant for Vasomotor Symptoms Associated With Menopause in Japan
jRCT2031210334Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fezolinetant in menopause and hot flash (3 arms), sponsored by Astellas Pharma. Started Nov 2021; status: completed.
02
Drugs
fezolinetant
03
Conditions
menopausehot flash
Beyond the preview
Go deeper on jRCT2031210334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210334.